Liver Tumor & Hepatoblastoma Clinic
The Pediatric Liver Tumor and Hepatoblastoma Clinic cares for infants, children and teens with liver or bile duct tumors. Our specialists diagnose and treat all types of pediatric liver cancer, including hepatoblastoma, childhood hepatocellular carcinoma, childhood undifferentiated embryonal sarcoma of the liver, and infantile choriocarcinoma of the liver. Because liver cancer is rare in children, each patient needs individualized care from experts. UCSF's international liver tumor board meets monthly to discuss challenging cases and optimize treatment strategies.
Our care team includes renowned pediatric specialists in cancer, surgery, gastroenterology, radiology, interventional radiology, medical genetics and pathology, as well as providers with expertise in specific types of pediatric liver cancer. In a setting thoughtfully designed to make kids and families feel comfortable, these doctors work closely together to ensure your child receives the best possible care.
What's more, we have the most advanced techniques available for diagnosing and treating children with liver or bile duct tumors. Imaging and genetic testing provide information about the specific tumor, which helps us to customize treatment plans. Our approach to your child's care may include conventional surgery, minimally invasive procedures, chemotherapy, and therapies that can target the specific molecular makeup of the tumor. When a liver transplant is necessary, we work with our Pediatric Liver Transplant Program, a national leader in transplantation that has made the process safer and more successful.
Throughout your child's time with us – from evaluation and diagnosis to treatment and follow-up – our social work and child life teams will be there for your family. These specialists provide information, connect you with resources and offer emotional support.
To make life easier during this challenging time, we offer video appointments in addition to in-person visits.
Our locations (1)
Our team
-
Kate Cheng
MD
Gastroenterologist and liver specialist -
Soo-Jin Cho
MD
Pediatric surgical pathologist -
Jesse Courtier
MD
Pediatric radiologist -
Nicholas Fidelman
MD
Interventional radiologist -
Sang-Mo Kang
MD
Organ transplant surgeon -
Amar Nijagal
MD
Pediatric surgeon -
Emily R. Perito
MD, MAS
Gastroenterologist and liver and pancreas specialist -
Arun Rangaswami
MD
Pediatric hematologist-oncologist -
Sue Rhee
MD
Gastroenterologist and liver specialist -
Alejandro Sweet-Cordero
MD
Pediatric hematologist-oncologist -
Lisa Gallagher
NP, MSN
Pediatric nurse practitioner -
Maura E. O'Day
PNP, MSN
Pediatric nurse practitioner -
Tracy Sirota
PNP, MSN
Pediatric nurse practitioner
Awards & recognition
-
Ranked among the nation's best in 11 specialties
-
One of the nation's best for gastroenterology & GI surgery
-
Best in Northern California for cancer care
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Our research initiatives
Support services
Clinical trials
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarco...
Estimated four year thoracic event free survival (tEFS) where tEFS is calculated as the time from study enrollment. Any recurrence within the pulmonary parenchyma, involving the pleural surface or the drain/surgical site wound wil...
Recruiting
More about this studyProject: Every Child for Younger Patients With Cancer
The number of patients who agree to be in the Biobanking part of the study and have leftover tumor tissue and some normal blood, bone marrow, or other tissue saved for future research.
Recruiting
More about this studyTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Adva...
Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).
Recruiting
More about this studyChemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusi...
The Kaplan-Meier method will be used to estimate 3-year FFS along with 80% log-minus-log transformed confidence limits for very low risk (VLR) patients.
Recruiting
More about this studyDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Child...
EFS time is calculated from time of randomization to Arms A or B to first episode of disease relapse or progression, second malignancy, or death, or until last contact if no event has occurred.
Recruiting
More about this studyA Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute ...
Summary statistics will be used to characterize the study populations on CHC outcomes. Quantitative data (number of comorbidities) will be summarized using descriptive statistics and correlational techniques. Will use pooled logis...
Recruiting
More about this studyET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinom...
Safety of ET140203 T cells as assessed by the number of adverse events (AEs) after infusion
Recruiting
More about this studyEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin ...
A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...
Recruiting
More about this studyTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Re...
Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score interval method.
Recruiting
More about this studyA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
For Strata 1-3, the primary analysis of EFS will consist of a one-sample, one-sided log rank test versus a historical control cohort (or representative distribution) with stratum-specific type I error levels. For Stratum 4, the pr...
Recruiting
More about this studyStaff superheroes